Fox Run Management L.L.C. Makes New Investment in Cigna Group $CI

Fox Run Management L.L.C. purchased a new position in shares of Cigna Group (NYSE:CI) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,280 shares of the health services provider’s stock, valued at approximately $1,178,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Cary Street Partners Investment Advisory LLC lifted its position in Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after purchasing an additional 36 shares during the last quarter. OLD National Bancorp IN lifted its position in Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after purchasing an additional 37 shares during the last quarter. CYBER HORNET ETFs LLC lifted its position in Cigna Group by 5.3% in the fourth quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock valued at $220,000 after purchasing an additional 40 shares during the last quarter. BNP Paribas lifted its position in Cigna Group by 0.7% in the fourth quarter. BNP Paribas now owns 5,676 shares of the health services provider’s stock valued at $1,566,000 after purchasing an additional 40 shares during the last quarter. Finally, Cookson Peirce & Co. Inc. lifted its position in Cigna Group by 0.8% in the third quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock valued at $1,428,000 after purchasing an additional 41 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $294.77 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a market cap of $77.97 billion, a PE ratio of 12.50, a P/E/G ratio of 1.12 and a beta of 0.28. The business has a 50 day moving average of $280.60 and a 200 day moving average of $277.57. Cigna Group has a 52 week low of $239.51 and a 52 week high of $338.89.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts forecast that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CI. Jefferies Financial Group lowered their price objective on Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Truist Financial boosted their price objective on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Raymond James Financial set a $340.00 price objective on Cigna Group in a research report on Friday, May 1st. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Finally, Barclays downgraded Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $310.00 to $304.00 in a research report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $338.80.

Insider Activity at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.